olmesartan has been researched along with Stroke in 12 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 4 (33.33) | 29.6817 |
| 2010's | 8 (66.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gelperin, K; Graham, DJ; Hsueh, YH; Levenson, MS; Rose, M; Zhou, EH | 1 |
| Bi, X; Shan, L; Wang, S; Zhou, Y | 1 |
| Camelo Castillo, W; Delaney, JA; Stürmer, T | 1 |
| Abe, K; Deguchi, K; Hishikawa, N; Ikeda, Y; Kono, S; Kurata, T; Liu, W; Omote, Y; Yamashita, T | 1 |
| Hayashi, K; Higaki, J; Horiuchi, M; Imaizumi, T; Ishimitsu, T; Ito, S; Kashihara, N; Katayama, S; Kimura, G; Matsuoka, H; Morita, S; Odawara, M; Ogihara, T; Rakugi, H; Saito, I; Saruta, T; Shimada, K; Shimamoto, K; Takishita, S; Tanahashi, N; Teramukai, S; Umemura, S; Ura, N | 1 |
| Díez-Tejedor, E; Fuentes, B; Gutiérrez-Fernández, M; Otero-Ortega, L; Ramos-Cejudo, J; Rodríguez-Frutos, B | 1 |
| Kawahira, K; Matsumoto, S; Miyata, R; Shimodozono, M | 3 |
| Araki, S; Hirooka, Y; Kishi, T; Sunagawa, K; Utsumi, H; Yasukawa, K | 1 |
| Chan, JC; Haneda, M; Imai, E; Ito, S; Kobayashi, F; Makino, H; Yamasaki, T | 1 |
| Achard, JM; Faure, S; Fournier, A; Javellaud, J; Oudart, N; Warnock, DG | 1 |
5 trial(s) available for olmesartan and Stroke
| Article | Year |
|---|---|
Combinations of olmesartan and a calcium channel blocker or a diuretic in elderly hypertensive patients: a randomized, controlled trial.
Topics: Aged; Aged, 80 and over; Angiotensin II Type 1 Receptor Blockers; Antihypertensive Agents; Blood Pressure; Calcium Channel Blockers; Diuretics; Drug Therapy, Combination; Female; Humans; Hypertension; Imidazoles; Incidence; Japan; Male; Prospective Studies; Stroke; Tetrazoles | 2014 |
Different protective and reparative effects of olmesartan in stroke according to time of administration and withdrawal.
Topics: Angiotensin II Type 1 Receptor Blockers; Animals; Brain-Derived Neurotrophic Factor; Disease Models, Animal; Double-Blind Method; Drug Administration Schedule; Female; Glial Fibrillary Acidic Protein; Imidazoles; In Situ Nick-End Labeling; Magnetic Resonance Imaging; Male; NADPH Oxidase 4; NADPH Oxidases; Rats; Rats, Sprague-Dawley; Severity of Illness Index; Statistics, Nonparametric; Stroke; Tetrazoles; Time Factors; Vascular Endothelial Growth Factor A | 2015 |
Benefits of the angiotensin II receptor antagonist olmesartan in controlling hypertension and cerebral hemodynamics after stroke.
Topics: Acetazolamide; Adult; Aged; Amlodipine; Angiotensin II Type 1 Receptor Blockers; Antihypertensive Agents; Blood Pressure; Calcium Channel Blockers; Cerebrovascular Circulation; Diuretics; Double-Blind Method; Female; Humans; Hypertension; Imidazoles; Male; Middle Aged; Prospective Studies; Stroke; Stroke Rehabilitation; Tetrazoles; Tomography, X-Ray Computed; Treatment Outcome; Young Adult | 2009 |
The angiotensin II type 1 receptor antagonist olmesartan preserves cerebral blood flow and cerebrovascular reserve capacity, and accelerates rehabilitative outcomes in hypertensive patients with a history of stroke.
Topics: Acetazolamide; Adult; Aged; Angiotensin II Type 1 Receptor Blockers; Blood Pressure; Brain; Female; Hemodynamics; Humans; Hypertension; Imidazoles; Male; Middle Aged; Regional Blood Flow; Stroke; Stroke Rehabilitation; Tetrazoles; Treatment Outcome | 2010 |
Effects of olmesartan on renal and cardiovascular outcomes in type 2 diabetes with overt nephropathy: a multicentre, randomised, placebo-controlled study.
Topics: Angiotensin II Type 1 Receptor Blockers; Antihypertensive Agents; Asian People; Cardiovascular Diseases; Creatinine; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Drug Therapy, Combination; Female; Humans; Hyperkalemia; Hypertension; Imidazoles; Kidney Failure, Chronic; Male; Middle Aged; Proteinuria; Stroke; Tetrazoles; Treatment Outcome | 2011 |
7 other study(ies) available for olmesartan and Stroke
| Article | Year |
|---|---|
Risk of acute myocardial infarction, stroke, or death in patients initiating olmesartan or other angiotensin receptor blockers - a cohort study using the Clinical Practice Research Datalink.
Topics: Adult; Aged; Aged, 80 and over; Angiotensin Receptor Antagonists; Cohort Studies; Databases, Factual; Diabetes Mellitus; Dose-Response Relationship, Drug; Female; Humans; Imidazoles; Male; Middle Aged; Myocardial Infarction; Proportional Hazards Models; Regression Analysis; Risk; Stroke; Tetrazoles | 2014 |
Orolingual angioedema associated with olmesartan use after recombinant tissue plasminogen activator treatment of acute stroke.
Topics: Acute Disease; Aged, 80 and over; Angioedema; Antihypertensive Agents; Female; Humans; Imidazoles; Lip; Methylprednisolone; Recombinant Proteins; Stroke; Tetrazoles; Tissue Plasminogen Activator; Tongue; Uvula | 2014 |
The challenges of comparing results between placebo controlled randomized trials and non-experimental new user, active comparator cohort studies: the example of olmesartan.
Topics: Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Cardiovascular Diseases; Diabetes Mellitus; Female; Humans; Imidazoles; Male; Myocardial Infarction; Stroke; Tetrazoles | 2014 |
Synergistic neuroprotective effects of combined treatment with olmesartan plus azelnidipine in stroke-prone spontaneously hypertensive rats.
Topics: Age Factors; Animals; Azetidinecarboxylic Acid; Blood Pressure; Brain Injuries; Chemokine CCL2; Collagen Type IV; Dihydropyridines; Disease Models, Animal; Drug Synergism; Drug Therapy, Combination; Gene Expression Regulation; Heart Rate; Imidazoles; Laser-Doppler Flowmetry; Male; Matrix Metalloproteinase 9; Motor Activity; Oxidative Stress; Rats; Rats, Inbred SHR; Stroke; Tetrazoles | 2014 |
Olmesartan reduces oxidative stress in the brain of stroke-prone spontaneously hypertensive rats assessed by an in vivo ESR method.
Topics: Angiotensin II Type 1 Receptor Blockers; Animals; Antihypertensive Agents; Blood Pressure; Brain; Electron Spin Resonance Spectroscopy; Heart Rate; Hydralazine; Hydrochlorothiazide; Hypertension; Imidazoles; Male; NADPH Oxidases; Norepinephrine; Oxidative Stress; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Stroke; Tetrazoles | 2009 |
Effect of the angiotensin II type 1 receptor antagonist olmesartan on cerebral hemodynamics and rehabilitation outcomes in hypertensive post-stroke patients.
Topics: Adult; Aged; Angiotensin II Type 1 Receptor Blockers; Antihypertensive Agents; Blood Pressure; Cerebrovascular Circulation; Female; Humans; Hypertension; Imidazoles; Male; Middle Aged; Stroke; Stroke Rehabilitation; Tetrazoles; Young Adult | 2009 |
Synergistic protective effects of erythropoietin and olmesartan on ischemic stroke survival and post-stroke memory dysfunctions in the gerbil.
Topics: Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Animals; Disease Models, Animal; Drug Therapy, Combination; Erythropoietin; Gerbillinae; Imidazoles; Kaplan-Meier Estimate; Male; Memory Disorders; Neuroprotective Agents; Ramipril; Recombinant Proteins; Stroke; Tetrazoles | 2006 |